Chen Xue-Rong, Zhang Wei-Zhong, Lin Xing-Qiu, Wang Jin-Wei
Department of Surgery, Taizhou First People's Hospital, Huangyan 318020, Zhejiang Province, China.
World J Gastroenterol. 2006 Jul 14;12(26):4246-9. doi: 10.3748/wjg.v12.i26.4246.
To investigate genetic instability of gene BRCA1 at locus D17S855, and their relationship with clinicopathological characteristics of gastric cancer in Chinese population.
Microsatellite instability (MSI) and loss of heterozygosity (LOH) of gene BRCA1 at locus D17S855 were compared between 37 samples of gastric cancer and corresponding non-cancerous gastric tissue.
MSI at locus D17S855 was positive in 7 of 37 samples of gastric cancer (18.95%). MSI had a close relationship with TNM staging but no relation with lymph node metastasis, histological type or tumor differentiation. MSI positive frequency in TNM I + II (31.58%, 6/19) was much higher than that in TNM III + IV (5.56%, 1/18), (P < 0.05). LOH positive rate was 18.92% (7/37). LOH had no relationship to histological type, tumor differentiation or lymph node metastasis, but LOH positive rate in TNM III + IV was 33.33% (6/18), much higher than that in TNM I + II ( 5.26%, 1/19), (P < 0.05). BRCA1 protein was expressed in 14 of 37 samples of gastric cancer. The positive rates of BRCA1 protein in TNM I + II and TNM III + IV were 57.89% and 16.67%, respectively, (P < 0.05). The positive rate of BRCA1 protein was 77.78% in high differentiation samples, 30.77% in middle differentiation and 12.50% in lower differentiation samples, (P < 0.05).
MSI of BRCA1 gene could be used as a molecular marker in early phases of sporadic gastric cancer in Chinese population. LOH occurs at later period of gastric cancer, therefore, it could be used as prognostic factor.
研究中国人群中基因BRCA1在D17S855位点的遗传不稳定性及其与胃癌临床病理特征的关系。
比较37例胃癌组织及其相应的癌旁胃组织中基因BRCA1在D17S855位点的微卫星不稳定性(MSI)和杂合性缺失(LOH)。
37例胃癌组织中,D17S855位点MSI阳性7例(18.95%)。MSI与TNM分期密切相关,与淋巴结转移、组织学类型或肿瘤分化无关。TNM I + II期MSI阳性率(31.58%,6/19)显著高于TNM III + IV期(5.56%,1/18),(P < 0.05)。LOH阳性率为18.92%(7/37)。LOH与组织学类型、肿瘤分化或淋巴结转移无关,但TNM III + IV期LOH阳性率为33.33%(6/18),显著高于TNM I + II期(5.26%,1/19),(P < 0.05)。37例胃癌组织中14例BRCA1蛋白表达阳性。TNM I + II期和TNM III + IV期BRCA1蛋白阳性率分别为57.89%和16.67%,(P < 0.05)。高分化样本中BRCA1蛋白阳性率为77.78%,中分化为30.77%,低分化为12.50%,(P < 0.05)。
BRCA1基因的MSI可作为中国人群散发性胃癌早期阶段的分子标志物。LOH发生于胃癌后期,因此可作为预后因素。